Orbimed leads investment in Genewiz

By Luisa Beltran — 4 weeks ago

OrbiMed has led an investment in Genewiz. Ampersand Capital Partners and Prime Value Capital Management also participated. Financial terms weren’t announced. South Plainfield, New Jersey-based Genewiz provides genomics services.

Continue

CutisPharma picks up funding from Ampersand

By Iris Dorbian — 1 year ago

CutisPharma has raised an undisclosed amount of equity funding from Ampersand Capital Partners. Silicon Valley Bank provided a senior credit facility to CutisPharma as part of the transaction. In addition to the financing, Ampersand’s Eric Lev and David Parker have been added to CutisPharma’s board of directors. Based in Wilmington, Mass., CutisPharma is a specialty pharmaceutical firm focused on developing value-added kits for the compounding pharmacy sector.

Continue

Ampersand-owned ATS Labs acquires MTL assets

By Iris Dorbian — 2 years ago

ATS Labs, which is owned by Ampersand Capital Partners, has bought the assets of Agawam, Mass.-based MicroTest Labs, a testing services provider for the medical device, pharmaceutical and biotech sectors. No financial terms were disclosed. The newly combined companies will soon be known as Accuratus Lab Services.

Continue

Square 1 Bank backs NutraMed

By Angela Sormani — 2 years ago

Square 1 Bank has provided a $12.5 million credit facility to NutraMed, a manufacturer of nutraceuticals and dietary supplements. Proceeds from the facility will be used in conjunction with an equity investment from Ampersand Capital Partners for acquisition financing and working capital.

Continue

Ampersand Capital Partners Adds Operating Partner

By Angela Sormani — 3 years ago

Healthcare-focused, middle market private equity firm Ampersand Capital Partners has appointed Cecil Kost as an operating partner. Kost will work with the Ampersand investment team to identify and evaluate new platform opportunities as well as assist on the existing portfolio.

Continue

Ampersand Expands Management Team

By Angela Sormani — 3 years ago

Ampersand Capital Partners, a healthcare-focused, middle market private equity firm, has made three appointments to its management team. Eric Lev has joined Ampersand as a partner, Dana Niles has joined Ampersand as the firm’s CFO and chief compliance officer and John Perkins has joined as an operating partner.

Continue

Lev, Niles Join Ampersand Capital

By Luisa Beltran — 3 years ago

Ampersand Capital Partners said Monday that Eric Lev has joined as a partner, while Dana Niles was named CFO and Chief Compliance Officer. John Perkins also joined Ampersand as an operating partner. Lev was most recently at Water Street Healthcare Partners where he served on their investment team. Niles previously was CFO of HighPoint Capital. And Perkins was a senior executive at Talecris Biotherapeutics, an Ampersand portfolio company.

Continue

Ampersand Capital Acquires Willow Laboratories

By Connie Loizos — 3 years ago

Willow Laboratories, based in Lynn, Mass., has been acquired by Ampersand Capital Partners. Willow is a clinical and forensic toxicology laboratory that provides urine, hair, and saliva testing services to a wide range of healthcare providers, including treatment centers. Ampersand is a Boston-based, middle market private equity firm. Terms of the deal were not disclosed.

Continue

Ampersand Sells MedVenture Technology

By Luisa Beltran — 3 years ago

Helix Medical has acquired MedVenture Technology Corp. Financial terms weren’t announced. The seller was Ampersand Capital Partners. MedVenture develops and manufactures minimally invasive surgical devices and catheter-based devices for medical device companies.

Continue

New PE-Backed Spinoff, Bioventus, Launches in Durham

By Connie Loizos — 4 years ago

Medical device company Smith & Nephew has launched a spinoff in Durham, N.C., called Bioventus. The company was formerly Smith & Nephew’s biologics division.Private equity firms Essex Woodlands, Pantheon Ventures, Spindletop Healthcare Capital, Alta Capital Partners, Ampersand Capital Partners, and White Pine Medical, are investing $118M to acquire 51% of Bioventus. PRESS RELEASE: Essex Woodlands […]

Continue